Embolotherapy Market 2027 By Product, Disease Indication, Procedure, End User and Geography | The Insight Partners

Embolotherapy Market to 2027 - Global Analysis and Forecasts by Product (Embolic Agents, Support Devices ); Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological and Nephrological Disorders, Gastrointestinal Disorders ); Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE) ); End User (Hospitals and Clinics, Ambulatory Surgery Centers, Other End Users ), and Geography

Report Code: TIPRE00006432 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION

Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils or gelfoam using an angiographic catheter. The catheter aids to block a blood vessel by implanting balloon or any foreign body, in order to treat bleeding ulcer, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defect or for control of inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.

MARKET DYNAMICS

The market for embolotherapy is forecasted to grow during the forecast years due to growing burden of target diseases, rising investments and technological advancements, growing investments by private players to develop innovative products and implants. Furthermore, rising demand for minimally invasive procedures, favorable reimbursement scenario for minimally invasive surgeries. The market is expected to experience several growth opportunities due to development in technology that enable to utilize different innovative materials for the embolotherapy in coming future.

MARKET SCOPE

The "Global Embolotherapy Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Embolotherapy market with detailed market segmentation by product, disease indication, procedure, end user and geography. The global Embolotherapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Embolotherapy market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global Embolotherapy market is segmented on the basis of product, disease indication, procedure, and end user. Based on the product the market is segmented as Embolic Agents, and Support Devices. Embolic agents segment is further sub segmented into, Microspheres, Embolic Coils Liquid Embolic Agents, Embolic Plug Systems, and Detachable Balloons. Support Devices is sub segmented into Microcatheters and Guidewires. On the basis of disease indication, embolotherapy market is classified as Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological & Nephrological Disorders and Gastrointestinal Disorders. Based on the procedure, the market is segmented as Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) and Transarterial Chemoembolization (TACE). On the basis of end user, the market is segmented into Hospitals and Clinics, Ambulatory Surgery Centers, and Other End Users


REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Embolotherapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Embolotherapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Embolotherapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Embolotherapy market in these regions.


MARKET PLAYERS


The reports cover key developments in the Embolotherapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Embolotherapy market are anticipated to lucrative growth opportunities in the future with the rising demand for Embolotherapy market in the global market. Below mentioned is the list of few companies engaged in the Embolotherapy market.

The report also includes the profiles of key Embolotherapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott Laboratories
  •  Acandis GmbH
  •  Balt Extrusion
  •  Boston Scientific Corporation
  •  BTG PLC
  •  Cook Medical
  •  Johnson & Johnson
  •  Kaneka Corporation
  •  Medtronic PLC
  •  Meril Life Sciences Pvt., Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Embolotherapy Market - By Product
1.3.2 Embolotherapy Market - By Disease Indication
1.3.3 Embolotherapy Market - By Procedure
1.3.4 Embolotherapy Market - By End User
1.3.5 Embolotherapy Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. EMBOLOTHERAPY MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. EMBOLOTHERAPY MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. EMBOLOTHERAPY MARKET - GLOBAL MARKET ANALYSIS

6.1. EMBOLOTHERAPY - GLOBAL MARKET OVERVIEW
6.2. EMBOLOTHERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT

7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EMBOLIC AGENTS
7.3.1. Overview
7.3.2. Embolic Agents Market Forecast and Analysis
7.3.3. Microspheres Market
7.3.3.1. Overview
7.3.3.2. Microspheres Market Forecast and Analysis
7.3.4. Embolic Coils Market
7.3.4.1. Overview
7.3.4.2. Embolic Coils Market Forecast and Analysis
7.3.5. Liquid Embolic Agents Market
7.3.5.1. Overview
7.3.5.2. Liquid Embolic Agents Market Forecast and Analysis
7.3.6. Embolic Plug Systems Market
7.3.6.1. Overview
7.3.6.2. Embolic Plug Systems Market Forecast and Analysis
7.3.7. Detachable Balloons Market
7.3.7.1. Overview
7.3.7.2. Detachable Balloons Market Forecast and Analysis
7.4. SUPPORT DEVICES
7.4.1. Overview
7.4.2. Support Devices Market Forecast and Analysis
7.4.3. Microcatheters Market
7.4.3.1. Overview
7.4.3.2. Microcatheters Market Forecast and Analysis
7.4.4. Guidewires Market
7.4.4.1. Overview
7.4.4.2. Guidewires Market Forecast and Analysis

8. EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION

8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CANCER
8.3.1. Overview
8.3.2. Cancer Market Forecast and Analysis
8.3.3. Liver Cancer Market
8.3.3.1. Overview
8.3.3.2. Liver Cancer Market Forecast and Analysis
8.3.4. Kidney Cancer Market
8.3.4.1. Overview
8.3.4.2. Kidney Cancer Market Forecast and Analysis
8.3.5. Other Cancers Market
8.3.5.1. Overview
8.3.5.2. Other Cancers Market Forecast and Analysis
8.4. PERIPHERAL VASCULAR DISEASE
8.4.1. Overview
8.4.2. Peripheral Vascular Disease Market Forecast and Analysis
8.5. NEUROLOGICAL DISEASES
8.5.1. Overview
8.5.2. Neurological Diseases Market Forecast and Analysis
8.6. UROLOGICAL AND NEPHROLOGICAL DISORDERS
8.6.1. Overview
8.6.2. Urological and Nephrological Disorders Market Forecast and Analysis
8.7. GASTROINTESTINAL DISORDERS
8.7.1. Overview
8.7.2. Gastrointestinal Disorders Market Forecast and Analysis

9. EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - PROCEDURE

9.1. OVERVIEW
9.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
9.3. TRANSCATHETER ARTERIAL EMBOLIZATION (TAE)
9.3.1. Overview
9.3.2. Transcatheter Arterial Embolization (TAE) Market Forecast and Analysis
9.4. TRANSCATHETER ARTERIAL RADIOEMBOLIZATION (TARE)/SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
9.4.1. Overview
9.4.2. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) Market Forecast and Analysis
9.5. TRANSARTERIAL CHEMOEMBOLIZATION (TACE)
9.5.1. Overview
9.5.2. Transarterial Chemoembolization (TACE) Market Forecast and Analysis

10. EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2027 - END USER

10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. AMBULATORY SURGERY CENTERS
10.4.1. Overview
10.4.2. Ambulatory Surgery Centers Market Forecast and Analysis
10.5. OTHER END USERS
10.5.1. Overview
10.5.2. Other End Users Market Forecast and Analysis

11. EMBOLOTHERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

11.1. NORTH AMERICA
11.1.1 North America Embolotherapy Market Overview
11.1.2 North America Embolotherapy Market Forecasts and Analysis
11.1.3 North America Embolotherapy Market Forecasts and Analysis - By Product
11.1.4 North America Embolotherapy Market Forecasts and Analysis - By Disease Indication
11.1.5 North America Embolotherapy Market Forecasts and Analysis - By Procedure
11.1.6 North America Embolotherapy Market Forecasts and Analysis - By End User
11.1.7 North America Embolotherapy Market Forecasts and Analysis - By Countries
11.1.7.1 United States Embolotherapy Market
11.1.7.1.1 United States Embolotherapy Market by Product
11.1.7.1.2 United States Embolotherapy Market by Disease Indication
11.1.7.1.3 United States Embolotherapy Market by Procedure
11.1.7.1.4 United States Embolotherapy Market by End User
11.1.7.2 Canada Embolotherapy Market
11.1.7.2.1 Canada Embolotherapy Market by Product
11.1.7.2.2 Canada Embolotherapy Market by Disease Indication
11.1.7.2.3 Canada Embolotherapy Market by Procedure
11.1.7.2.4 Canada Embolotherapy Market by End User
11.1.7.3 Mexico Embolotherapy Market
11.1.7.3.1 Mexico Embolotherapy Market by Product
11.1.7.3.2 Mexico Embolotherapy Market by Disease Indication
11.1.7.3.3 Mexico Embolotherapy Market by Procedure
11.1.7.3.4 Mexico Embolotherapy Market by End User
11.2. EUROPE
11.2.1 Europe Embolotherapy Market Overview
11.2.2 Europe Embolotherapy Market Forecasts and Analysis
11.2.3 Europe Embolotherapy Market Forecasts and Analysis - By Product
11.2.4 Europe Embolotherapy Market Forecasts and Analysis - By Disease Indication
11.2.5 Europe Embolotherapy Market Forecasts and Analysis - By Procedure
11.2.6 Europe Embolotherapy Market Forecasts and Analysis - By End User
11.2.7 Europe Embolotherapy Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Embolotherapy Market
11.2.7.1.1 Germany Embolotherapy Market by Product
11.2.7.1.2 Germany Embolotherapy Market by Disease Indication
11.2.7.1.3 Germany Embolotherapy Market by Procedure
11.2.7.1.4 Germany Embolotherapy Market by End User
11.2.7.2 France Embolotherapy Market
11.2.7.2.1 France Embolotherapy Market by Product
11.2.7.2.2 France Embolotherapy Market by Disease Indication
11.2.7.2.3 France Embolotherapy Market by Procedure
11.2.7.2.4 France Embolotherapy Market by End User
11.2.7.3 Italy Embolotherapy Market
11.2.7.3.1 Italy Embolotherapy Market by Product
11.2.7.3.2 Italy Embolotherapy Market by Disease Indication
11.2.7.3.3 Italy Embolotherapy Market by Procedure
11.2.7.3.4 Italy Embolotherapy Market by End User
11.2.7.4 Spain Embolotherapy Market
11.2.7.4.1 Spain Embolotherapy Market by Product
11.2.7.4.2 Spain Embolotherapy Market by Disease Indication
11.2.7.4.3 Spain Embolotherapy Market by Procedure
11.2.7.4.4 Spain Embolotherapy Market by End User
11.2.7.5 United Kingdom Embolotherapy Market
11.2.7.5.1 United Kingdom Embolotherapy Market by Product
11.2.7.5.2 United Kingdom Embolotherapy Market by Disease Indication
11.2.7.5.3 United Kingdom Embolotherapy Market by Procedure
11.2.7.5.4 United Kingdom Embolotherapy Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Embolotherapy Market Overview
11.3.2 Asia-Pacific Embolotherapy Market Forecasts and Analysis
11.3.3 Asia-Pacific Embolotherapy Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Embolotherapy Market Forecasts and Analysis - By Disease Indication
11.3.5 Asia-Pacific Embolotherapy Market Forecasts and Analysis - By Procedure
11.3.6 Asia-Pacific Embolotherapy Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Embolotherapy Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Embolotherapy Market
11.3.7.1.1 Australia Embolotherapy Market by Product
11.3.7.1.2 Australia Embolotherapy Market by Disease Indication
11.3.7.1.3 Australia Embolotherapy Market by Procedure
11.3.7.1.4 Australia Embolotherapy Market by End User
11.3.7.2 China Embolotherapy Market
11.3.7.2.1 China Embolotherapy Market by Product
11.3.7.2.2 China Embolotherapy Market by Disease Indication
11.3.7.2.3 China Embolotherapy Market by Procedure
11.3.7.2.4 China Embolotherapy Market by End User
11.3.7.3 India Embolotherapy Market
11.3.7.3.1 India Embolotherapy Market by Product
11.3.7.3.2 India Embolotherapy Market by Disease Indication
11.3.7.3.3 India Embolotherapy Market by Procedure
11.3.7.3.4 India Embolotherapy Market by End User
11.3.7.4 Japan Embolotherapy Market
11.3.7.4.1 Japan Embolotherapy Market by Product
11.3.7.4.2 Japan Embolotherapy Market by Disease Indication
11.3.7.4.3 Japan Embolotherapy Market by Procedure
11.3.7.4.4 Japan Embolotherapy Market by End User
11.3.7.5 South Korea Embolotherapy Market
11.3.7.5.1 South Korea Embolotherapy Market by Product
11.3.7.5.2 South Korea Embolotherapy Market by Disease Indication
11.3.7.5.3 South Korea Embolotherapy Market by Procedure
11.3.7.5.4 South Korea Embolotherapy Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Embolotherapy Market Overview
11.4.2 Middle East and Africa Embolotherapy Market Forecasts and Analysis
11.4.3 Middle East and Africa Embolotherapy Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Embolotherapy Market Forecasts and Analysis - By Disease Indication
11.4.5 Middle East and Africa Embolotherapy Market Forecasts and Analysis - By Procedure
11.4.6 Middle East and Africa Embolotherapy Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Embolotherapy Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Embolotherapy Market
11.4.7.1.1 South Africa Embolotherapy Market by Product
11.4.7.1.2 South Africa Embolotherapy Market by Disease Indication
11.4.7.1.3 South Africa Embolotherapy Market by Procedure
11.4.7.1.4 South Africa Embolotherapy Market by End User
11.4.7.2 Saudi Arabia Embolotherapy Market
11.4.7.2.1 Saudi Arabia Embolotherapy Market by Product
11.4.7.2.2 Saudi Arabia Embolotherapy Market by Disease Indication
11.4.7.2.3 Saudi Arabia Embolotherapy Market by Procedure
11.4.7.2.4 Saudi Arabia Embolotherapy Market by End User
11.4.7.3 U.A.E Embolotherapy Market
11.4.7.3.1 U.A.E Embolotherapy Market by Product
11.4.7.3.2 U.A.E Embolotherapy Market by Disease Indication
11.4.7.3.3 U.A.E Embolotherapy Market by Procedure
11.4.7.3.4 U.A.E Embolotherapy Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Embolotherapy Market Overview
11.5.2 South and Central America Embolotherapy Market Forecasts and Analysis
11.5.3 South and Central America Embolotherapy Market Forecasts and Analysis - By Product
11.5.4 South and Central America Embolotherapy Market Forecasts and Analysis - By Disease Indication
11.5.5 South and Central America Embolotherapy Market Forecasts and Analysis - By Procedure
11.5.6 South and Central America Embolotherapy Market Forecasts and Analysis - By End User
11.5.7 South and Central America Embolotherapy Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Embolotherapy Market
11.5.7.1.1 Brazil Embolotherapy Market by Product
11.5.7.1.2 Brazil Embolotherapy Market by Disease Indication
11.5.7.1.3 Brazil Embolotherapy Market by Procedure
11.5.7.1.4 Brazil Embolotherapy Market by End User
11.5.7.2 Argentina Embolotherapy Market
11.5.7.2.1 Argentina Embolotherapy Market by Product
11.5.7.2.2 Argentina Embolotherapy Market by Disease Indication
11.5.7.2.3 Argentina Embolotherapy Market by Procedure
11.5.7.2.4 Argentina Embolotherapy Market by End User

12. INDUSTRY LANDSCAPE

12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. EMBOLOTHERAPY MARKET, KEY COMPANY PROFILES

13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ACANDIS GMBH
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BALT EXTRUSION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BOSTON SCIENTIFIC CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BTG PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. COOK MEDICAL
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. JOHNSON AND JOHNSON
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. KANEKA CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MEDTRONIC PLC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MERIL LIFE SCIENCES PVT., LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX

14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Acandis GmbH
3. Balt Extrusion
4. Boston Scientific Corporation
5. BTG PLC
6. Cook Medical
7. Johnson & Johnson
8. Kaneka Corporation
9. Medtronic PLC
10. Meril Life Sciences Pvt., Ltd.